Cipher Pharmaceuticals Inc

Cipher Pharmaceuticals is a growing specialty pharmaceutical company that commercializes novel formulations of successful, currently marketed molecules. Cipher's first product is a fenofibrate formulation marketed in the United States as Lipofen. Cipher's second product, an extended-release tramadol, is marketed in the United States as ConZip and in Canada as Durela.